Evidence map›Paper›PMID 39790076›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2025

Detection of vaccine-derived poliovirus type 2 from sewage samples and public health response, Poland, November to December 2024.

Magdalena Wieczorek, Beata Gad, Arleta Krzysztoszek, Paulina Kłosiewicz, Kinga Oleksiak, Bartosz Zaborski, Paweł Grzesiowski, Katarzyna Tkaczuk, Anna Baumann-Popczyk

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Poliovirus detections in Europe - urgent action needed to keep Europe polio-free.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Magdalena WieczorekDepartment of Virology, National Institute of Public Health NIH - National Institute of Research, Warsaw, Poland.
Beata GadDepartment of Virology, National Institute of Public Health NIH - National Institute of Research, Warsaw, Poland.
Arleta KrzysztoszekDepartment of Virology, National Institute of Public Health NIH - National Institute of Research, Warsaw, Poland.
Paulina KłosiewiczDepartment of Virology, National Institute of Public Health NIH - National Institute of Research, Warsaw, Poland.
Kinga OleksiakDepartment of Virology, National Institute of Public Health NIH - National Institute of Research, Warsaw, Poland.
Bartosz ZaborskiBureau of Research and Technology, MPWIK SA (Municipal Water Supply and Sewerage Company in Warsaw), Warsaw, Poland.
Paweł GrzesiowskiThe Chief Sanitary Inspector, Chief Sanitary Inspectorate, Warsaw, Poland.
Katarzyna TkaczukDepartment for Communicable Disease Prevention and Control, Chief Sanitary Inspectorate, Warsaw, Poland.
Anna Baumann-PopczykDepartment for Communicable Disease Prevention and Control, Chief Sanitary Inspectorate, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In October and December 2024, circulating vaccine-derived poliovirus type 2 (cVDPV2) was detected from two wastewater samples in Poland during routine environmental surveillance. The first isolate was characterised and matched previous cVDPV2 isolates detected in Spain in September, as well as in Germany, Finland, and the United Kingdom in November and December 2024. In response to the event, active surveillance for acute flaccid paralysis (AFP) has been strengthened, and the frequency of environmental sample collection has been increased.

Indexed as

PoliomyelitisPoliovirusSewageDisease OutbreaksEnvironmental MonitoringHumansPolandPoliovirus Vaccine, OralPublic HealthWastewater-Based Epidemiological MonitoringPoliovirus Vaccine, OralSewagecVDPV2environmental surveillanceNIE-ZAS-1 emergence grouppolio virus

Identifiers

PMID39790076
PMCPMC11719809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.